Theon Pharmaceuticals Limited - Company Profile

Q: Who are the current directors of Theon Pharmaceuticals Limited?

The current directors of Theon Pharmaceuticals Limited are Vidushi Khattar, Amit Kumar Bansal, Mukesh Bansal, Manish Bansal, Niveta Rampaul Sharma, Sharad Kumar Saxena, Puneet Bansal, Puran Chand Joshi, Anshul Bansal, Surbhi Verma, Aaditya Kumar Bansal, Himanshu Bansal.

It is a pharma public limited company based in Chandigarh, Chandigarh, India, established in 2005.

2005 Chandigarh, Chandigarh, India Active

Last Updated: January 10, 2026

Access Report

About Theon Pharmaceuticals Limited

Theon Pharmaceuticals Limited, a active public limited company, was established on 26 May 2005 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231CH2005PLC028465. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹17.44 Cr.

It upholds a compliant status. Employing 700 professional, Its leadership includes Vidushi Khattar (Director), Amit Kumar Bansal (Managing Director), Mukesh Bansal (Director). Past directors included Gaurav Goyal, Shiana Bansal, Vidushi Khattar. It holds ₹281.80 Cr open charges and ₹35.44 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 29/4 Industrial Area, Phase 2, Chandigarh, Chandigarh, 160002.

Company Details

CIN/LLPIN
U24231CH2005PLC028465
Registration Number
028465
Incorporation Date
26 May 2005
Authorized Capital
₹20.00 Cr
Paid-Up Capital
₹17.44 Cr
ROC Code
Roc Chandigarh
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 20.00 Cr as on 10-01-2026
Paid Up Capital ₹ 17.44 Cr as on 10-01-2026
Company Age 20 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 281.80 Cr as on 10-01-2026
Satisfied Charges ₹ 35.44 Cr as on 10-01-2026
Revenue Growth **** -4.94% (FY 2023)
Profit Growth **** -51.16% (FY 2023)
Ebitda **** -54.01% (FY 2023)
Net Worth 4.41% (FY 2023)
Total Assets **** 5.30% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Theon Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Theon Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vidushi Khattar	Director	20 Nov 2019	Current
Amit Kumar Bansal	Managing Director	08 Jul 2005	Current
Mukesh Bansal	Director	27 May 2005	Current
Manish Bansal	Whole-Time Director	08 Jul 2005	Current
Niveta Rampaul Sharma	Additional Director	01 Feb 2025	Current
Puneet Bansal	Whole-Time Director	10 May 2006	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	06 Jan 2016	Past
Pramod Abcsdd	Whole-Time Director	01 Sep 2016	Past
Pramod Abcsdd	Additional Director	30 Dec 2020	Past
Pramod Abcsdd	Whole-Time Director	01 Sep 2016	Past
Pramod Abcsdd	Director	06 Jan 2016	Past
Pramod Abcsdd	Additional Director	30 Sep 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Theon Pharmaceuticals.

Theon Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.94% decrease. The company also saw a substantial fall in profitability, with a 51.16% decrease in profit. The company's net worth moved up by a moderate rise of 4.41%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-4.94%

*******

Revenue from Operations

*******

-5.48%

*******

Total Assets

*******

5.30%

*******

Profit or Loss

*******

-51.16%

*******

Net Worth

*******

4.41%

*******

EBITDA

*******

-54.01%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Theon Pharmaceuticals?

In 2023, Theon Pharmaceuticals had a promoter holding of 63.86% and a public holding of 36.14%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,818,000,000.00

Satisfied Charges

₹354,430,000.00

Charges Breakdown by Lending Institutions

Others : 148.00 Cr
Hdfc Bank Limited : 73.50 Cr
Axis Bank Limited : 60.00 Cr
Governor Of Himachal Pradesh (Through Gm Industries Centre) : 0.30 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Mar 2025	Others	₹6.00 Cr	Open
05 Mar 2025	Others	₹60.00 Cr	Open
25 Apr 2024	Others	₹30.00 Cr	Open
17 Mar 2023	Hdfc Bank Limited	₹28.50 Cr	Open
23 Mar 2022	Axis Bank Limited	₹60.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Theon Pharmaceuticals?

Theon Pharmaceuticals has a workforce of 700 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Theon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theon Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Theon Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Progress on Aaditya Kumar Bansal was appointed as a Director was appointed as a Director on 10 Nov 2025 & has been associated with this company since 3 months 21 days . was documented.
10 Nov 2025
Director Appointment

Progress on Himanshu Bansal was appointed as a Director was appointed as a Director on 10 Nov 2025 & has been associated with this company since 3 months 21 days . was documented.
10 Nov 2025
Annual General Meeting

Theon Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Director Appointment

The activity Surbhi Verma was appointed as a Company Secretary was appointed as a Company Secretary on 06 May 2025 & has been associated with this company since 9 months 26 days . was completed.
06 May 2025
Balance Sheet

Progress on Theon Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was documented.
31 Mar 2025
Charges

The activity A charge with Others amounted to Rs. 6.00 Cr with Charge ID 101085382 was registered on 28 Mar 2025. was completed.
28 Mar 2025

Explore recent activity and updates - View Recent Activity